Form 13-F position report

ROIVANT SCIENCES LTD

Reported by Whitefort Capital Management LP

ROIV CUSIP G76279101 Manager CIK 0001884931

Reported 639,000 shares, down 380,000 (37.3%) from the prior quarter.

Reported value -35.2%; share count -37.3% vs. the prior quarter.

Reduced
% of reported 13F value 5.03% This manager · Q3 2026
Shares 639,000 Quarter-end amount reported
Reported value $23,368,230 Fair value at quarter end
Consecutive quarters held 12 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 11253683
2023-03-31 6151016
2023-06-30 0
2023-12-31 17866930
2024-03-31 25201140
2024-06-30 25272870
2024-09-30 27592140
2024-12-31 28285530
2025-03-31 34416990
2025-06-30 43750140
2025-09-30 53439160
2025-12-31 46004000
2026-03-31 39306300
2026-06-30 36062410
2026-09-30 23368230

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for ROIVANT SCIENCES LTD held by Whitefort Capital Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 639,000 -380,000 (-37.3%) 5.03% $23,368,230 2026-11-16
Q2 2026 Reduced 1,019,000 -400,000 (-28.2%) 8.89% $36,062,410 2026-08-14
Q1 2026 Reduced 1,419,000 -701,000 (-33.1%) 11.59% $39,306,300 2026-05-15
Q4 2025 Reduced 2,120,000 -1,412,000 (-40.0%) 11.76% $46,004,000 2026-02-17
Q3 2025 Reduced 3,532,000 -350,000 (-9.0%) 15.79% $53,439,160 2025-11-14
Q2 2025 Added 3,882,000 +471,000 (13.8%) 16.4% $43,750,140 2025-08-14
Q1 2025 Added 3,411,000 +1,020,000 (42.7%) 16.19% $34,416,990 2025-05-15
Q4 2024 Unchanged 2,391,000 0 (0.0%) 13.54% $28,285,530 2025-02-14
Q3 2024 Unchanged 2,391,000 0 (0.0%) 12.56% $27,592,140 2024-11-14
Q2 2024 Unchanged 2,391,000 0 (0.0%) 15.58% $25,272,870 2024-08-14
Q1 2024 Added 2,391,000 +800,000 (50.3%) 15.35% $25,201,140 2024-05-15
Q4 2023 New 1,591,000 +1,591,000 (0.0%) 11.39% $17,866,930 2024-02-14
Q2 2023 Reduced 0 -833,471 (-100.0%) 0 $0 2023-08-14
Q1 2023 Reduced 833,471 -575,000 (-40.8%) 5.72% $6,151,016 2023-05-12
Q4 2022 New 1,408,471 +1,408,471 (0.0%) 8.74% $11,253,683 2023-02-14

Who else reported the position

597 managers reported ROIVANT SCIENCES LTD for Q3 2026.

Managers reporting ROIVANT SCIENCES LTD in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 85,575,553 +4,555,163 0.13% $3,129,497,953 20 qtrs
BlackRock Inc Added 61,879,232 +13,643,141 0.03% $2,262,923,497 9 qtrs
MORGAN STANLEY Reduced 38,603,606 -3,989,299 0.07% $1,411,733,957 20 qtrs
QVT Financial LP Unchanged 23,723,074 0 48.22% $867,552,816 20 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 23,127,563 +1,004,365 0.02% $845,774,979 3 qtrs
STATE STREET CORPORATION Added 22,399,587 +4,603,612 0.02% $819,152,897 20 qtrs
FARALLON CAPITAL MANAGEMENT LLC Added 21,745,533 +7,436,533 3.43% $795,234,142 14 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 21,657,255 +15,916 0.04% $792,005,815 3 qtrs
UBS Group AG Reduced 13,928,426 -3,538,215 0.07% $509,362,539 16 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 12,521,620 +847,240 0.02% $467,988,217 20 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
SHS

Voting authority reported

Sole
639,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.